Mirapexin (Pramipexole Dihydrochloride Monohydrate)

Mirapexin (pramipexole) is a dopamine agonist used in the management of movement disorders.

• Parkinson's disease (early stage): Helps control motor symptoms and may delay the need for levodopa.
• Parkinson's disease (advanced stage): Provides adjunctive therapy to reduce motor fluctuations.
• Restless legs syndrome: Decreases leg discomfort and the urge to move, improving sleep quality.

• Pramipexole acts as a selective agonist at dopamine D2 and D3 receptors in the brain. By binding to these receptors, it mimics the action of endogenous dopamine, enhancing dopaminergic neurotransmission in the basal ganglia and other motor control pathways. This stimulation compensates for the dopaminergic deficit characteristic of Parkinson's disease and modulates sensory pathways involved in restless legs syndrome.

Pramipexole may be associated with a range of adverse reactions, varying from mild to serious.

Common Side Effects

• Nausea: mild gastrointestinal upset.
• Dizziness: feeling light‑headed or unsteady.
• Somnolence: increased sleepiness or fatigue.
• Headache: mild to moderate head pain.
• Orthostatic hypotension: drop in blood pressure upon standing.
• Peripheral edema: swelling of the lower limbs.

Serious or Rare Side Effects

• Hallucinations: visual or auditory disturbances.
• Impulse control disorders: compulsive gambling, shopping, or eating.
• Sudden onset of sleep: episodes of unexpected sleep.
• Neuroleptic malignant-like syndrome: rare severe reaction with fever and rigidity.
• Severe depression or suicidal thoughts: worsening mood or suicidal ideation.
• Allergic reactions: rash, swelling, or anaphylaxis.

When prescribing Mirapexin, clinicians should consider several precautionary measures to ensure safe use.

• Renal impairment: adjust dose in patients with reduced kidney function.
• Cardiovascular disease: monitor for orthostatic hypotension and arrhythmias.
• Psychiatric history: watch for hallucinations, depression, or impulse control changes.
• Elderly patients: start at low dose and titrate slowly due to increased sensitivity.
• Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Pramipexole can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

• Antipsychotics (e.g., haloperidol, risperidone): may antagonize dopamine agonist effect.
• MAO‑B inhibitors (e.g., selegiline): increase risk of hypertensive reactions.

Moderate Interactions (Monitor Closely)

• CNS depressants (e.g., alcohol, benzodiazepines): may enhance somnolence.
• Antihypertensive agents: additive effect on blood pressure, monitor for hypotension.
• Serotonergic drugs (e.g., SSRIs): potential for serotonin syndrome, observe symptoms.
• Dopamine antagonists (e.g., metoclopramide): may reduce therapeutic benefit.